Form 4 Filing for Celldex Therapeutics, Inc. - Officer/Director Stock Option Grant

This filing reports the grant of 375,000 Incentive Stock Options to Marucci Anthony S, President & CEO of Celldex Therapeutics, Inc. The options were granted on June 25, 2026, under the company's 2021 Omnibus Equity Incentive Plan. The exercise price is $34.09 per share. Vesting begins on June 25, 2027, with 25% vesting on that date, followed by quarterly vesting over the subsequent 12 quarters. The options are exercisable until June 25, 2036. The reporting owner, Marucci Anthony S, is a director and officer of the company. The filing is a Form 4, indicating a change in beneficial ownership.